Application | Comment | Organism |
---|---|---|
medicine | good drug targets for the treatment of inflammatory disorders and other pathologies involving selectins | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
wild-type and mutant enzymes expressed in CHO-K1 cells | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
T60A | about 65% of the wild-type in vitro activity, mutation results in a significant increase in electrophoretic mobilities of the protein | Homo sapiens |
T60A/T97A | about 6% of the wild-type in vitro activity, mutant loses the ability of branching P-selectin glycoprotein ligand-1 O-glycans | Homo sapiens |
T97A | about 25% of the wild-type in vitro activity, mutation results in a significant increase in electrophoretic mobilities of the protein | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Homo sapiens | key enzyme for the biosynthesis of sialyl-Lewis x determinants on selectin ligands | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
glycoprotein | for C2GnT-I, the N-glycan chain linked to Asn-95 significantly contributes to the synthesis of functional P-selectin glycoprotein ligand-1 and is required to localize the enzyme to the cis/medial-Golgi compartment | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | key enzyme for the biosynthesis of sialyl-Lewis x determinants on selectin ligands | Homo sapiens | ? | - |
? | |
UDP-N-acetyl-D-glucosamine + Galbeta1,3GalNAc-O-p-nitrophenyl | - |
Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
C2GnT-I | - |
Homo sapiens |
core2 beta(1,6)-N-acetyglucosaminyltransferase-I | - |
Homo sapiens |